Lumpy Skin Disease Returns to Europe: Outbreaks, Impacts, and Urgent Measures

In the summer of 2025, Europe has been confronted with a resurgence of Lumpy Skin Disease (LSD)—a highly contagious viral disease affecting cattle and other ruminants. For the first time, Italy and France have reported confirmed outbreaks, prompting swift action from veterinary authorities and international health organizations 

https://wahis.woah.org/ (accessed 27th July, 2025) 

What Is Lumpy Skin Disease?

LSD is caused by a capripoxvirus and is primarily transmitted through biting insects such as mosquitoes and flies. While it poses no risk to human health, its impact on animal welfare and agricultural economies is severe. Infected animals suffer from fever, nodular skin lesions, swollen lymph nodes, and in some cases, death. The disease also leads to reduced milk production, weight loss, and reproductive issues, making it a major threat to livestock productivity 

The 2025 Outbreaks: A New Front in Europe

The World Organisation for Animal Health (WOAH) confirmed outbreaks in Sardinia and Lombardy (Italy) on June 23, followed by a case in eastern France near the Swiss border on June 30 . These are the first-ever confirmed cases in these countries, marking a significant geographic expansion of the disease in Europe.

The outbreaks have triggered emergency containment measures, including:

• Immediate culling of infected herds
• Movement restrictions on cattle
• Enhanced surveillance and vector control
• Suspension of bovine imports from affected regions by countries like the UK

Consequences for Trade and Agriculture

The economic fallout is already being felt. The UK has banned imports of certain bovine products from France and Italy, including some unpasteurized cheeses. This has raised concerns about broader trade disruptions and market instability, especially in the dairy sector.

The Role of Vaccination and Biosecurity

Vaccination remains the most effective tool for controlling LSD. WOAH emphasizes the importance of early detection, movement control, and high-quality vaccines as part of a coordinated response. However, as highlighted in a recent Animal Health Update, vaccine uptake remains inconsistent across regions due to logistical and financial barriers.

The outbreaks also underscore the need for cross-border collaboration and science-based communication. WOAH has warned against misinformation, particularly around vaccine safety and milk consumption, which can undermine public trust and disrupt market.

Looking Ahead: A Call for Preparedness

The re-emergence of LSD in Europe is a stark reminder of the growing threat of transboundary animal diseases, potentially exacerbated by climate change and global trade. For companies like TechMix, this presents both a challenge and an opportunity—to contribute meaningfully to the animal health toolbox through nutritional solutions, strategic alliances, and proactive communication.